Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

A novel CLDN1 mutation in a 2-month-old with NISCH showed improvement with symptom management.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Adalimumab improved folliculitis decalvans in most patients.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

The FDA approved a new Pfizer drug for hair loss in teens.

Olumiant should be covered for severe alopecia areata if certain conditions are met.